Parallel Advisors’s Bionano Genomics BNGO Stock Holding History

Parallel Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Hold	0	–	-$4	–	3381
2023 Q2	–	Hold	0	–	–	–	3349
2023 Q1	–	Hold	0	–	–	–	3407
2022 Q4	–	Hold	0	–	–	–	3330
2022 Q3	–	Hold	0	–	–	–	3154
2022 Q2	–	Hold	0	–	–	–	3013
2022 Q1	–	Hold	0	–	–	–	2986
2021 Q4	–	Sell	-1	Closed	-$2K	–	3092
2021 Q3	$2K	Hold	1	–	–	﹤0.01%	2654
2021 Q2	$3K	Hold	1	–	–	﹤0.01%	2435
2021 Q1	$3K	Buy	+1	New	+$5.64K	﹤0.01%	2339

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Parallel Advisors's BNGO Position: Q3 2023 in Review

Parallel Advisors held its Bionano Genomics (BNGO) position steady in Q3 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3381.

Parallel Advisors first reported a position in BNGO in Q1 2021 and has held it in 3 quarters since. The position peaked at $3K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Parallel Advisors held 0 shares of Bionano Genomics worth $0 as of Q3 2023.
Parallel Advisors left its Bionano Genomics share count unchanged in Q3 2023.
Bionano Genomics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2023, its #3381 holding.
Parallel Advisors first reported a position in Bionano Genomics in Q1 2021 and has held it in 3 quarters since.
Parallel Advisors's Bionano Genomics position peaked at $3K in Q2 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.